Vester-Andersen, M. K.
Mirsepasi-Lauridsen, H. C.
Prosberg, M. V.
Mortensen, C. O. http://orcid.org/0000-0003-3738-168X
Träger, C.
Skovsen, K.
Thorkilgaard, T.
Nøjgaard, C.
Vind, I.
Krogfelt, K. A. http://orcid.org/0000-0001-7536-3453
Sørensen, N.
Bendtsen, F.
Petersen, A. M. http://orcid.org/0000-0003-0531-0553
Article History
Received: 13 March 2019
Accepted: 23 August 2019
First Online: 17 September 2019
Competing Interests
: Flemming Bendtsen: Takeda. Ida Vind: Speaker/advisory board member/PI: Takeda, TIllots Pharma, Pfizer, Janssen, Abbvie A/S. Marianne Vester-Andersen: Lecture fee from AbbVie A/S. The remaining part of the authors has no conflicts of interest.